Technical Analysis for KALA - Kala Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 4.55 0.66% 0.03
KALA closed up 0.66 percent on Thursday, September 19, 2019, on 62 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical KALA trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Weak + Overbought Other 0.00%
Inside Day Range Contraction 0.00%
Weak, Overbought and Reversal Signs Reversal 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%

Older signals for KALA ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Kala Pharmaceuticals Inc. is a United States-based company that is developing ophthalmic treatments based on the Company’s Mucosal Penetrating Product (MPP) platform. The Company’s topical ocular MPP formulations enhance penetration of diverse therapeutic agents into ocular tissue, including those in the back of the eye, by facilitating penetration through the mucus layer of tear film. Its product development pipeline includes a 1% formulation of loteprednol etabonate to treat post-surgical ocular inflammation and pain; a 0.25% LE-MPP formulation for dry eye, blepharitis, and retinal disease, and a topically applied receptor tyrosine kinase inhibitir (RTKi-MPP) for the treatment of wet age-related macular degeneration (AMD).
Medicine Medical Specialties Pain Organ Systems Macular Degeneration Wet Age Related Macular Degeneration Glucocorticoids Retinal Disease Post Surgical Ocular Inflammation
Is KALA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 11.09
52 Week Low 3.5
Average Volume 328,287
200-Day Moving Average 6.1668
50-Day Moving Average 4.7606
20-Day Moving Average 4.046
10-Day Moving Average 4.218
Average True Range 0.2729
ADX 27.51
+DI 22.5787
-DI 16.4423
Chandelier Exit (Long, 3 ATRs ) 3.8612
Chandelier Exit (Short, 3 ATRs ) 4.3187
Upper Bollinger Band 4.5655
Lower Bollinger Band 3.5265
Percent B (%b) 0.99
BandWidth 25.679684
MACD Line -0.0508
MACD Signal Line -0.1792
MACD Histogram 0.1284
Fundamentals Value
Market Cap 110.23 Million
Num Shares 24.2 Million
EPS -32.85
Price-to-Earnings (P/E) Ratio -0.14
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.73
Resistance 3 (R3) 4.73 4.68 4.70
Resistance 2 (R2) 4.68 4.63 4.68 4.69
Resistance 1 (R1) 4.61 4.60 4.59 4.61 4.68
Pivot Point 4.56 4.56 4.54 4.56 4.56
Support 1 (S1) 4.49 4.51 4.47 4.49 4.42
Support 2 (S2) 4.44 4.48 4.44 4.41
Support 3 (S3) 4.37 4.44 4.40
Support 4 (S4) 4.37